Anuh Pharma Ltd

Anuh Pharma announced that the revised record date for payment of final dividend for FY 2024-25 is 15 August 2025. Powered by Capital Market - Live

The Board of Anuh Pharma at its meeting held on 16 July 2025 has allotted 5,01,12,000 fully paid up equity shares of face value of Rs 5 each in ratio of 1:1. Consequently, the paid up equity share capital has increased to 10,02,24,000 equity shares of Rs 5 each aggregating to Rs 50,11,20,000/-.Powered by Capital Market - Live

In a regulatory filing, the company stated that the new facility is expected to become operational within July 2025. Upon commencement, the plant will expand Anuh Pharma's manufacturing capacity by an additional 200 metric tons per annum (MT/Annum). Post-expansion, the company's total production capacity will increase from approximately 2,200 MT/Annum to 2,400 MT/Annum. The newly inaugurated INT-1A block is also equipped with an additional 40 kiloliters (KL) of reactor capacity, enhancing the company's infrastructure and positioning it to meet growing market demand more effectively. Anuh Pharma, a bulk drug manufacturing company, is part of the Rs 8.5 bn SK Group of Companies, which employs 2000+ people across businesses such as manufacturing of APIs, pharma formulations, distribution, and logistics. Established in 1960, Anuh Pharma today is one of the largest manufacturers of macrolides and anti-TB products in India, besides being a major player in anti-bacterials, anti-malarials, and corticosteroids. The company's standalone net profit fell 18.9% to Rs 12.46 crore, while revenue from operations jumped 20.9% to Rs 198.14 crore in Q4 March 2025 over Q4 March 2024. Powered by Capital Market - Live

Anuh Pharma has fixed 15 July 2025 as record date for issuance of bonus shares in ratio of 1:1. Powered by Capital Market - Live

Anuh Pharma announced that the 65th Annual General Meeting(AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live

Anuh Pharma announced that the Board of Directors of the Company at its meeting held on 23 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 30%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Anuh Pharma declined 18.88% to Rs 12.46 crore in the quarter ended March 2025 as against Rs 15.36 crore during the previous quarter ended March 2024. Sales rose 20.90% to Rs 198.14 crore in the quarter ended March 2025 as against Rs 163.89 crore during the previous quarter ended March 2024. For the full year,net profit declined 21.16% to Rs 47.35 crore in the year ended March 2025 as against Rs 60.06 crore during the previous year ended March 2024. Sales rose 2.24% to Rs 661.51 crore in the year ended March 2025 as against Rs 647.00 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales198.14163.89 21 661.51647.00 2 OPM %9.4311.73 -9.2111.61 - PBDT20.0521.95 -9 69.7586.89 -20 PBT17.2919.72 -12 61.0178.31 -22 NP12.4615.36 -19 47.3560.06 -21 Powered by Capital Market - Live

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live

Net profit of Anuh Pharma declined 45.89% to Rs 10.34 crore in the quarter ended December 2024 as against Rs 19.11 crore during the previous quarter ended December 2023. Sales declined 7.32% to Rs 159.51 crore in the quarter ended December 2024 as against Rs 172.10 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales159.51172.10 -7 OPM %9.2713.93 - PBDT15.4427.50 -44 PBT13.2625.30 -48 NP10.3419.11 -46 Powered by Capital Market - Live

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - Live